Ellenbogen Michael 4

What Happened
Michael Ellenbogen, a director of Evolv Technologies Holdings (EVLV), exercised stock options and immediately sold the resulting 80,745 shares on April 15, 2026. He paid $0.24 per share to exercise (total cost $19,379) and sold the shares in the open market for a weighted-average price of $6.32, generating proceeds of about $510,308. The filing also includes a related derivative conversion entry reported at $0.00.

Key Details

• Transaction date: April 15, 2026; Form 4 filed April 17, 2026.
• Exercise: 80,745 shares exercised at $0.24 per share (total $19,379). (Code M)
• Sale: 80,745 shares sold at a weighted-average price of $6.32 for proceeds ≈ $510,308. (Code S)
• Sale price range: $6.27 to $6.39 across multiple trades (footnote).
• Plan: Sales were executed pursuant to a Rule 10b5-1 trading plan entered June 12, 2025 (footnote).
• Vesting note: The option vests began Jan 31, 2018 with subsequent monthly vesting (footnote).
• Shares owned after transaction: Not specified in the provided filing.
• Timeliness: Filed two days after the transaction date (not indicated as late).

Context
This was an option exercise followed by immediate sale (a common "cashless" pattern for insiders converting options to cash). The 10b5-1 plan means the sales were pre-arranged. The filing is factual and does not by itself indicate the director’s view of the company’s prospects.